Internal Medicine, Nephrology · Phoenix, AZ
NPI
1740462431
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
2545 E Thomas Rd, Suite 120
Phoenix, AZ, 85016
Phone (602) 419-3378
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,623 services
Medicare patients, 2024
325
Average age 65
Drug cost, 2024
$137K
1,732 prescriptions
Company payments, 2025
$1,505
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ibrahim Qaqish was code 99233 (hospital e&m - subsequent), 468 times for 144 patients. In total Ibrahim Qaqish billed 1,623 services in 17 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 468 | 144 | $81.58 | $38K |
| 99215 Office E&M - Established | Office | 302 | 136 | $129.67 | $39K |
| 99214 Office E&M - Established | Office | 77 | 56 | $88.61 | $6,823 |
| 99223 Hospital E&M - Initial | Facility | 66 | 63 | $120.24 | $7,936 |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 25 | $58.65 | $2,463 |
| 99443 Telephone Services | Office | 19 | 19 | $93.40 | $1,775 |
By year: 2022 $103K for 1,796 services; 2023 $118K for 2,187 services; 2024 $104K for 1,623 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ibrahim Qaqish prescribed most often to Medicare patients was Fluconazole, with 302 prescriptions and refills. In total Ibrahim Qaqish wrote 1,732 Medicare prescriptions that cost $137K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluconazole Generic | 302 | 473 | 69 | $12K |
| Prednisone Generic | 190 | 285 | 49 | $968 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 107 | 129 | 33 | $892 |
| Carvedilol Generic | 90 | 175 | 30 | $584 |
| Tamsulosin Hcl Generic | 67 | 113 | 16 | $761 |
| Famotidine Generic | 67 | 126 | 22 | $556 |
| Valganciclovir Hcl Generic | 63 | 65 | 27 | $9,157 |
| Nifedipine Er Nifedipine | 57 | 106 | 19 | $784 |
| Amlodipine Besylate Generic | 53 | 105 | 15 | $405 |
| Atorvastatin Calcium Generic | 47 | 79 | 14 | $306 |
| Losartan Potassium Generic | 44 | 102 | 12 | $531 |
| Cinacalcet Hcl Generic | 43 | 69 | 16 | $3,144 |
| Metoprolol Tartrate Generic | 42 | 73 | 11 | $237 |
| Hydralazine Hcl Generic | 39 | 57 | Under 11 | $307 |
| Pantoprazole Sodium Generic | 37 | 92 | 15 | $419 |
Brand drugs: 85 claims; generic drugs: 1,624 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ibrahim Qaqish $1,505 ($1,505 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $253.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 8 | $253 |
| Merck Sharp & Dohme LLC MRK | 8 | $155 |
| Mallinckrodt Hospital Products Inc. | 1 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $145 |
| Novo Nordisk Inc NVO | 2 | $135 |
| Akebia Therapeutics Inc AKBA | 1 | $122 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $121 |
| Lilly USA, LLC LLY | 1 | $119 |
| Veloxis Pharmaceuticals, Inc. | 2 | $63.15 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $52.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.